Amlodipine, a calcium channel blocker, treats high blood pressure, angina, and coronary artery disease. Learn about 12 important drug interactions.

Amlodipine/atorvastatin combination pill approved by FDA. Shelley Wood. February 03, 2004. Tue, 03 Feb 2004 17:45:00 Rockville, MD - The US FDA has granted marketing approval for a dual therapy ...

Data show that treatment with a single-pill combination of telmisartan, an angiotensin receptor blocker, (ARB) and amlodipine, a calcium channel block ...

March 11, 2004 (New Orleans) — The recently approved fixed-dose combination pill, combining amlodipine and atorvastatin (two of the most important components of the so-called "poly-pill") is an ...

Amlodipine is one of the drugs in this combination product. If you develop sudden or worsening chest pain after starting this drug or increasing your dosage, call 911 or go to the nearest ...

Basel, August 27, 2010 - The US Food and Drug Administration (FDA) today approved Tekamlo® (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the ...

The Food and Drug Administration (FDA) has approved Widaplik ™ (telmisartan, amlodipine and indapamide), a single pill combination therapy, for the treatment of hypertension, including as ...

The generic drug company Mylan Pharmaceuticals recalled 104 lots of three medications: valsartan tablets, combination tablets with the drugs valsartan and amlodipine, and combination tablets with ...

Carduo 10mg/5mg - 10 Tablets (Amlodipine - Combination of Generics) drug information. Find its price or cost, dose, when to use, how to use, side effects, adverse effects, substitutes . It is ...

For the two phase 3 GMRx2 trials, researchers evaluated the safety and efficacy of single combination triple therapy pill containing low dose indapamide, amlodipine and telmisartan for the ...

London, United Kingdom – 31 August 2024: A low-dose triple single-pill combination was effective at lowering blood pressure (BP) in two trials presented in a Hot Line session today at ESC ...